Waagsbø, Bjørn
Buset, Eva Margrethe
Longva, Jørn-Åge
Bjerke, Merete
Bakkene, Birgitte
Ertesvåg, Anne-Stine
Holmen, Hanne
Nikodojevic, Marko
Tran, To Thy
Christensen, Andreas
Nilsen, Einar
Damås, Jan Kristian
Heggelund, Lars
Article History
Received: 19 October 2021
Accepted: 16 February 2022
First Online: 2 March 2022
Declarations
:
: The protocol for each study year was evaluated and approved by the Regional Committees for Medical and Health Research Ethics, Norwegian University of Science and Technology NTNU/Regional Ethic Committee Central, Faculty of Medicine, Pb 8905, 7491 Trondheim. Approval number was 2017/1439, head of secretariat Hilde Eikemo. Data protection officials, and hospital administrations for both health trusts also approved the study. The study was conducted in line with the conclusion from the Regional Committees for Medical and Health Research Ethics, Central, that informed consents were not required to access or publish the data. An informed consent waiver was obtained from the St. Olavs hospital, Trondheim University Hospital. This consent waiver was evaluated by the Regional Comittees for Medical and Health Research Central, before approval of the study. Consent to participate was not obtained. The study was conducted in accordance with the principles of the Declaration of Helsinki, and the guidelines for medical and health research from The Norwegian National Research Ethics Committees.
: No.
: The authors mentioned below have no relevant financial or non-financial interests to disclose. Eva Margrethe Buset, Jørn-Åge Longva, Merete Bjerke, Birgitte Bakkene, Anne-Stine Ertesvåg, Hanne Holmen, Marko Nikodojevic, To Thy Tran, Andreas Christensen, Einar Nilsen, Jan Kristian Damås, Lars Heggelund. Author Bjørn Waagsbø is a representative to the directory group in the Norwegian Directorate of Health, that seek to revise recommendations in the national clinical practice guideline for antimicrobial therapy, and holds a 20% position for this representation between 2018 and 2021.